Gene Query: SPATA13

Dataset Description Geneva Score
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 50.77
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 50.77
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 49.62
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 46.13
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 46.13
RNA-seq of human fibroblasts after irradiation 45.83
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 39.52
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 39.52
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 38.11
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 36.08
Transcriptomic profiling of human peripheral blood-derived mast cells 36.08
Differential expression of genes in AD169-infected MRC5. 36.05
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 33.6
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 32.9
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 31.74
RNA-seq of young and quiescent MRC-5 human fibroblasts 31.33
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 31.1
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 31.1
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 30.97
Paxillin regulates genomic networks in prostate cancer [C4-2] 30.94
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 30.15
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 29.99
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 29.27
A prostate cancer chromatin interaction map 29.26
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 29.03
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 27.81
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 27.81
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 27.16
Transcriptome of Stabilin-1 siRNA transfected human monocytes 26.2
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 25.33
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 25.13
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 25.04
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 25.02
RNA-seq data from human lymphoma cell lines 24.98
ChIP-seq and RNA-seq from human lymphoma cell lines 24.98
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 24.62
WRN knockout effects upon gene expression in SW48 and OVK18 24.6
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 23.3
CircRNAome diversity in human mature B-cells, T-cells and monocytes 23.12
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 22.3
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 22.01
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 20.77
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 20.52
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 20.52
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 20.4
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 20.4
RNAseq analysis of ESRP regulated splicing events in prostate cancer 20.01
The effect of insulin on mRNA transcription of human pluripotent stem cells 19.79
Oncogenic MYC induces a dependency on the spliceosome in human cancer 19.74
FOXP1 orchestration of ASD-relevant signaling pathways. 19.62
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 19.51
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 19.23
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 18.97
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 18.62
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 18.61
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 18.58
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 18.58
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 17.91
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 17.56
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 17.56
snRNAs as regulators of alternative splicing 17.5
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 17.3
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 17.28
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 16.93
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 16.75
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 16.75
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 16.57
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 16.52
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 16.41
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 16.16
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 16.14
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 16.14
Crizotinib v. DMSO in SW480 cells 16.07
Tumor exosome integrins determine organotropic metastasis 15.98
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 15.98
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 15.9
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 15.76
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 15.75
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 15.61
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 15.57
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 15.57
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 15.46
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 15.45
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 15.45
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 15.29
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 15.25
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 15.21
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 15.2
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 14.94
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 14.57
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 14.53
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 14.53
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 14.49
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 14.47
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 14.37
Transcriptomic profile of human embryonic renal corpuscles 14.33
Transcriptome analysis of human lung epithelial cells 14.31
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 14.29
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 14.28
NR2F2 study 14.28
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 14.15
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 14.0
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 13.95
Silencing p300 in MCF7 cells to study expression and alternative splicing 13.88
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 13.83
RNA-seq analysis of BAP1-depleted uveal melanoma cells 13.81
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 13.77
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 13.77
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 13.64
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 13.63
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 13.63
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 13.52
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 13.48
Short and Long RNA sequencing of human mature erythrocytes 13.45
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 13.3
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 13.3
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 13.27
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 13.27
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 13.24
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 13.24
Transcriptome profiling of Normal and Cancerous Prostate Cells 13.18
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 13.17
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 13.04
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 13.0
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 13.0
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 12.89
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 12.88
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  12.84
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 12.82
RNA-seq of naive and primed ES cells (NHSM) 12.7
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 12.69
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 12.64
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 12.63
Regionally specified human pluripotent stem cell-derived astrocytes 12.63
Differential Gene Expression between MCF10A and MCF7 cells 12.25
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 12.15
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 12.03
MCF-7 as a model for functional analysis of breast cancer risk variants 11.92
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 11.88
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 11.88
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 11.88
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 11.74
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 11.68
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 11.68
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 11.65
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 11.58
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 11.56
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 11.55
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 11.49
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 11.44
RNA-Seq from early time points in the kidney differentiation protocol 11.41
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 11.4
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 11.38
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 11.21
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 11.21
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 11.14
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 11.1
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 11.08
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 11.05
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 10.88
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 10.88
PGE2 mediated gene expression changes in human cervical stromal cells 10.85
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 10.81
Differential analysis of gene regulation at transcript resolution by RNA-Seq 10.73
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 10.73
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 10.69
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 10.64
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 10.43
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 10.39
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 10.3
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 10.19
Induced DNA demethylation, genome instability and transcription 10.17
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 10.17
Gene expression changes upon drug withdrawal (Mel888 cell line) 10.1
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 10.09
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 10.09
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 10.03
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 10.03
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 9.96
PTHrP overexpression in MCF7 cells 9.93
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 9.91
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 9.88
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 9.88
Integrating single-cell transcriptomic data across different conditions, technologies, and species 9.85
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 9.83
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 9.82
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 9.8
Defective structural RNA processing in relapsing-remitting multiple sclerosis 9.78
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 9.7
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 9.7
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 9.68
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 9.66
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 9.65
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 9.65
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 9.63
The transcriptome effect of overexpressing EZH2 in MCF7 9.59
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 9.56
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 9.56
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 9.43
An acquired vulnerability of drug resistant melanoma with therapeutic potential 9.37
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 9.37
Effects of rFVIIIFc on human macrophages 9.32
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 9.29
Zika virus directly infects human peripheral neurons and induces cell death 9.27
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 9.26
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 9.26
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 9.26
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 9.25
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 9.25
DJ-1 is dispensable for human stem cell homeostasis 9.24
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 9.21
RNA-seq melanoma 9.21
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 9.19
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 9.16
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 9.09
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 9.08
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 9.08
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 9.07
A Unique Epigenomic Landscape Defines Human Erythropoiesis 9.07
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 9.07
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 9.0
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 8.93
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 8.74
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 8.7
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.67
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 8.66
Active translatome profiling with RiboLace in MCF7 cells 8.62
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 8.61
Targeting MTHFD2 in Acute Myeloid Leukemia 8.6
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 8.59
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 8.58
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 8.57
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 8.53
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 8.52
A novel target of EZH1/2 for treatment of mantle cell lymphoma 8.45
Ectoderm specification of H1 human embryonic stem cells 8.41
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 8.32
RNAseq Analysis in glioblastoma cells treated with Mepazine 8.29
Gene expression in PANC1 cells treated with Rakicidin 8.27
AR-independent prostate cancer is sustained through FGF signaling 8.26
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 8.22
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 8.21
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 8.14
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 8.13
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 8.1
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 8.09
Role for citron kinase in prostate cancer growth 7.98
BCL11B 7.94
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 7.88
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 7.86
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 7.85
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 7.78
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 7.78
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 7.77
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 7.72
Differential gene expression of human melanoma cells [RNA-seq] 7.7
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 7.7
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 7.62
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 7.54
mRNA-Seq profiling of human developing kidney 7.49
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 7.44
Subtle asymmetry of gene expression in embryonic and foetal human brains 7.41
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 7.37
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 7.26
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.15
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 7.13
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 7.07
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 7.01
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 7.01
Identification of differentially expressed genes between senescence and senescence bypass cells 7.0
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 6.94
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 6.94
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 6.87
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 6.87
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 6.83
Gene expression signatures of innate lymphoid cells from human blood 6.83
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 6.83
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 6.8
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 6.77
Role of FGFR1 in neuronal devlopment 6.77
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 6.72
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 6.69
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 6.6
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 6.58
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 6.51
Role of COP1 on MAP kinase transcriptional output in melanoma 6.5
RNA sequencing analysis of selumetinib-resistant CRC cells lines 6.42
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 6.39
Identification of HOXB13 target genes responsive to BET inhibitors 6.33
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 6.29
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 6.29
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 6.29
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 6.28
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 6.22
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 6.21
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 6.19
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 6.19
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 6.16
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 6.07
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 5.96
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 5.81
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 5.77
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 5.76
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 5.74
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 5.63
Transcriptome of diurnal human blood neutrophils 5.61
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 5.61
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 5.59
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 5.49
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 5.48
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 5.46
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 5.46
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 5.43
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 5.38
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 5.34
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 5.31
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 5.31
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 5.28
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 5.28
The role of CFTR in islet function 5.26
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 5.25
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 5.25
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 5.23
The cohesin release factor WAPL restricts chromatin loop extension. 5.23
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.22
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.22
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 5.2
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 5.15
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 5.12
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 5.07
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 4.97
Epigenetic reprogramming of melanoma cells by vitamin C treatment 4.89
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 4.89
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 4.87
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 4.76
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 4.76
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 4.72
Changes in human endometrial gland transcriptome over the window of implantation 4.7
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 4.59
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 4.58
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 4.57
Novel Targeting of Transcription and Metabolism in Glioblastoma 4.56
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 4.55
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 4.47
Primate-specific gene TMEM14B promotes cortical expansion and folding 4.42
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.41
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 4.41
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 4.37
LINE-2 transposable elements are a source of functional human microRNAs and target sites 4.37
Proteomics identifies a marker signature of MAPKi resistance in melanoma 4.35
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.21
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 4.2
iPSC derived motor neuron cultures from C9ORF72 carriers 4.19
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 4.18
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 4.18
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 4.18
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 4.17
Transcriptomic analysis of human tonsillar TFH subsets 4.11
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.09
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 4.03
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 3.97
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.96
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 3.92
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 3.92
AMPK signaling for naïve pluripotency 3.9
AMPK signaling for naïve pluripotency [Hs] 3.9
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 3.88
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 3.86
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 3.84
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.82
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 3.81
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 3.8
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 3.79
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 3.76
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.75
Gene expression profile of human placenta from T. Cruzi infected mothers 3.74
Trascriptome of thyroid cancer-induced macrophages 3.67
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.62
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 3.51
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 3.46
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 3.46
Activity-dependent transcriptional changes in human neurons 3.45
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.44
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 3.38
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 3.38
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 3.36
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 3.35
RNA-seq analysis of the human fetal kidney. 3.33
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.3
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.3
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 3.26
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 3.24
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 3.21
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 3.21
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 3.14
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 3.11
Disruption of GRIN2B impairs differentiation in human neurons 2.99
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 2.96
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 2.96
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 2.93
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 2.9
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 2.83
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 2.83
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 2.83
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 2.82
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 2.74
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 2.74
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.73
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.72
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 2.7
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.64
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.59
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.58
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.58
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 2.55
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 2.52
Identification of renal resident macrophages across species [C1] 2.49
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.44
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.44
Dissecting neural differentiation regulatory networks through epigenetic footprinting 2.42
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.41
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 2.39
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.39
Total RNA-Seq data from leukemic patients with complex structural variants 2.32
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 2.18
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 2.16
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 2.08
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 2.04
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.03
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.02
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.01
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 1.96
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.86
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.86
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.81
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.67
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.66
NAPRT activation of macrophages 1.63
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 1.58
Transcriptome analysis of peripheral blood monocytes 1.52
Polarized B -cell functions 1.51
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 1.46
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.44
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 1.42
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 1.42
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 1.38
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 1.38
Identification of renal resident macrophages across species 1.37
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 1.31
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.29
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 1.28
Human Tfh cell RNA bulk sequencing 1.27
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.21
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.13
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 1.11
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.08
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 1.01
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.99
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 0.92
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.87
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.86
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 0.86
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.86
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.84
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.8
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.8
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.74
Investigate A2M treatment on human prostate cancer xenograft in mice 0.73
Investigate A2M treatment on human prostate cancer and mouse liver 0.73
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.71
oxLDL exposed trained monocytes 0.7
Transcriptomes of oxLDL exposed trained monocytes 0.7
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.67
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.66
Transcriptional responses of melanoma cells to BRAF inhibition 0.61
JAK dependent survival of ALK- ALCL 0.59
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.58
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.57
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.56
Aging-associated patterns in the expression of human endogenous retroviruses 0.56
Expression profiles of the four human major ectodermal lineages 0.52
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.41
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 0.34
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.33
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.31
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.29
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.28
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.26
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.25
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.21
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.21
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.17
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.17
Transcriptomic analysis of human macrophages in 3D 0.14
The role of the Calcium-Sensing receptor in colorectal cancer 0.14
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.09
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.07
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.03
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.03
Expression analysis of the TAF1 syndrome 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation